Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.
- Resource Type
- Article
- Source
- Targeted Oncology; 2021, Vol. 16 Issue 1, p59-68, 10p
- Subject
- Language
- ISSN
- 17762596